Print

29 Meta-analysis of tight control strategies in rheumatoid arthritis: protocolized treatment has additional value with respect to the clinical outcome. Schipper LG, van Hulst LTC, Grol R, van Riel PLCM, Hulscher ME, Fransen J.Rheumatology 2010;49(11):2154-64

28 DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis. Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Kerstens PJ, Nielen MM, Vos K, van Schaardenburg D, Speyer I, Seys PE, Breedveld FC, Allaart CF, Dijkmans BA. Ann Rheum Dis 2010;69(1):65-9

27 Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot trial. van Tuyl LH, Lems WF, Voskuyl AE, Kerstens PJ, Garnero P, Dijkmans BA, Boers M. Ann Rheum Dis 2008;67(11):1574-77

26 Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility. Bakker MF, Jacobs JW, Verstappen SM, Bijlsma JW. Ann Rheum Dis 2007;66(3):iii56-60

25 How does one assess early rheumatoid arthritis in daily clinical practice? Van Riel PLCM, Schumacher HR. Best Pract Res Clin Rheumatol 2001;15(1):67-76.

24 The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Welsing PMJ, Van Gestel AM, Swinkels HL, Kiemeney LALM, Van Riel PLCM. Arthritis Rheum 2001;44(9):2009-17.

23 Improvement criteria--clinical and statistical significance: comment on the article by Pincus and Stein. van Gestel AM, van Riel PL. Arthritis Rheum 2000 Jul;43(7):1658-60

22 Discriminating ability of composite indices for measuring disease activity in rheumatoid arthritis: a comparison of the Chronic Arthritis Systemic Index, Disease Activity Score and Thompson's articular index. Salaffi F, Peroni M, Ferraccioli GF. Rheumatology (Oxford) 2000 Jan;39(1):90-6

21 Evaluation of established rheumatoid arthritis. van Gestel AM, Stucki G. Baillieres Best Pract Res Clin Rheumatol 1999 Dec;13(4):629-44

20 Equivalence of the acute phase reactants C-reactive protein, plasma viscosity, and Westergren erythrocyte sedimentation rate when used to calculate American College of Rheumatology 20% improvement criteria or the Disease Activity Score in patients with early rheumatoid arthritis. Western Consortium of Practicing Rheumatologists. Paulus HE, Ramos B, Wong WK, Ahmed A, Bulpitt K, Park G, Sterz M, Clements P. J Rheumatol 1999 Nov;26(11):2324-31

19 ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology. van Gestel AM, Anderson JJ, van Riel PL, Boers M, Haagsma CJ, Rich B, Wells G, Lange ML, Felson DT. J Rheumatol 1999 Mar;26(3):705-11

18 Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. van Gestel AM, Haagsma CJ, van Riel PL. Arthritis Rheum 1998 Oct;41(10):1845-50

17 The original "DAS" and the "DAS28" are not interchangeable: comment on the articles by Prevoo et al. van der Heijde DM, Jacobs JW. Arthritis Rheum 1998 May;41(5):942-5

16 Evaluation of early rheumatoid arthritis disease activity and outcome. van Gestel AM, van Riel PL. Baillieres Clin Rheumatol 1997 Feb;11(1):49-63

15 Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score. Prevoo ML, van Gestel AM, van T Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL. Br J Rheumatol 1996 Nov;35(11):1101-5

14 Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score. Prevoo ML, van Gestel AM, van T Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL. Br J Rheumatol 1996 Nov;35(11):1101-5

13 Development and validation of response criteria in rheumatoid arthritis: steps towards an international consensus on prognostic markers. van Riel PL, van Gestel AM, van de Putte LB. Br J Rheumatol 1996 Sep;35 Suppl 2:4-7

12 Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. van Gestel AM, Prevoo ML, van 't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL. Arthritis Rheum 1996 Jan;39(1):34-40

11 Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Arthritis Rheum 1995 Jan;38(1):44-8

10 The use of the disease activity score in the analysis of clinical trials in rheumatoid arthritis. Fuchs HA. J Rheumatol 1993 Nov;20(11):1863-6

9 Development of a disease activity score based on judgment in clinical practice by rheumatologists. van der Heijde DM, van 't Hof M, van Riel PL, van de Putte LB. J Rheumatol 1993 Mar;20(3):579-81

8 Validity of single variables and indices to measure disease activity in rheumatoid arthritis. van der Heijde DM, van 't Hof M, van Riel PL, van de Putte LB. J Rheumatol 1993 Mar;20(3):538-41

7 Provisional guidelines for measuring disease activity in RA clinical trials. van Riel PLCM. Editorial. Br J Rheumatol 1992; 31:793-794

6 Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients. van der Heijde DMFM, van Riel PLCM, Leeuwen MA, van 't Hof MA, van Rijswijk MH, van de Putte LBA. Br J Rheumatol 1992; 31:519-525

5 Long-term second-line treatment: a prospective drug survival study. Wijnands MJH, van 't Hof MA, van Leeuwen MA, van Rijswijk MH, van de Putte LBA, van Riel PLCM. Br J Rheumatol 1992; 31:253-258

4 Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis. van der Heijde DMFM, van Leeuwen MA, van Riel PLCM, Koster AM, van 't Hof MA, van Rijswijk MH, van de Putte LBA. Arthritis Rheum 1992; 35:26-34

3 Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis. van der Heijde DMFM, van 't Hof MA, van Riel PLCM, van Leeuwen MA, van Rijswijk MH, van de Putte LBA. Ann Rheum Dis 1992; 51:177-181

2 Judging disease activity in clinical practice in rheumatoid arthritis. First step in the development of a 'disease activity score'. van der Heijde DMFM, van 't Hof MA, van Riel PLCM, Theunisse HAM, Lubberts EW, van Leeuwen MA, van Rijswijk MH, van de Putte LBA Ann Rheum Dis 1990; 49:916-920 40.

1 Association of HLA antigens, toxic reactions and therapeutic response to auranofin and aurothioglucose in patients with rheumatoid arthritis. van Riel PLCM, Reekers P, van de Putte LBA, Gribnau FWJ. Tissue Antigens 1983; 22:194-199

 

 


 

You are here:   HomeLiterature